Homa index in healthy subjects;Determinación del índice homa en sujetos presuntamente sanos. Estudio epidemiológico multicéntrico (resultados preliminares)

Revista Argentina de Endocrinologia y Metabolismo

Volumn 42, Issue 1, 2005, Pages 12-19

  Graffigna, Mabel Nora ^b,i   Litwak, L ^c   Abdala, María Marta ^d   Akel, M E ^a   Aranda, C ^b   Gutt, Susana ^c   Ledesma, Laura ^c   Levalle, O ^b   Marcial Toro, J ^e   Migliano, Marta ^f   Perez De La Puente M ^b   Pombo, F ^g   Rodríguez, Mirta ^b   Scaliter, H ^h   Tarruella, M ^f   Yuma, María ^c   Cavallero, Elizabeth ^h  

^a Buenos Aires)   (Argentina)

^b HOSPITAL DURAND   (Argentina)

^c Hospital Italiano de Bs As   (Argentina)

^d Hospital General De Agudos Teodoro Alvarez   (Argentina)

^e Hospital Aeronautico   (Argentina)

^f HOSPITAL NACIONAL PROFESOR ALEJANDRO POSADAS   (Argentina)

^g Fundacion Hematologica Sarmiento

^h HOSPITAL RAMOS MEJÍA   (Argentina)

ⁱ Franklin 1996 Departamento C   (Argentina)

Author keywords

Cardiovascular risk factors; Healthy subjects; HOMA; Insulin resistance; Metabolic Syndrome

Indexed keywords

GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; ARTICLE; BLOOD PRESSURE; BODY HEIGHT; BODY MASS; BODY WEIGHT; CARDIOVASCULAR DISEASE; CHOLESTEROL BLOOD LEVEL; FEMALE; GLUCOSE BLOOD LEVEL; GLUCOSE CLAMP TECHNIQUE; HOMA INDEX; HUMAN; HYPERCHOLESTEROLEMIA; HYPERGLYCEMIA; HYPERINSULINEMIA; HYPERTENSION; INSULIN RESISTANCE; MAJOR CLINICAL STUDY; MALE; METABOLIC PARAMETERS; METABOLIC SYNDROME X; OBESITY; PANCREAS ISLET BETA CELL; PHYSICAL ACTIVITY; RISK FACTOR; WAIST CIRCUMFERENCE;

EID: 20544458291     PISSN: 03264610     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Ascaso, J.E; Pardo, S.; Real, J.T. y col. Diagnosing Insulin Resistance by Simple Quantitative Methods in Subjects UIT Normal Glucose Metabolism. Diabetes Care 26: 3320-3324, 2003.
2. Martín, B.C.; Warram, J.H.; Ktolewski, A.S. y col. Role of glucose and insulin resistance in development of type 2 diabetes mellitus: Results of a 25-year follow-up. Lancet 340: 925-929, 1992.
3. Lillioja, S.; Mott, D.M.; Spraul, M. y col. Insulin resistance and insulin secretory dysfunction as precursors of non-insulin-dependent diabetes mellitus: Prospective studies of Pima Indians. N Engl J Med 329: 1988-1992, 1993.
4. Despres, J.P.; Lamarche, B.; Mauriege, P. y col. Hiperinsulinemia as an independent risk factor for ischemic heart disease. N Engl J Med 11: 952-957, 1996.
5. Reaven, G.M. Role of insulin resistance in human disease. Banting Lecture 1988. Diabetes 37: 1595-1607, 1988.
6. Report of a WHO Consultation. In Alwan, A.; King, H. eds. Definition, Diagnosis and Classification of Diabetes Mellitus and its Complications. Part 1: Diagnosis and Classification of Diabetes Mellitus. Geneva: World Health Organization, Department of Noncommunicable Disease Surveillance; 1-59, 1999.
7. DeFronzo, R.A.; Tobin, J.D.; Andres, R. The glucose clamp technique: a method for the quantification of beta cell sensitivity to glucose and of tissue sensitivity to insulin. Am J Phisiol 237: E214-E223, 1979.
8. Matthews D.R.; Hosker J.P.; Rudensky B.A. y col. Homeostasis model assessment: insulin resistance and b- cell function from fasting plasma glucose and insulin concentrations in man. Diabetología 28: 412-419, 1985.
9. Haffner, S.M.; Miettinen, H.; Stern, M. P. The Homeostasis Model in the San Antonio Heart Study. Diabetes Care 20: 1087-1092, 1997.
10. Bonora, E.; Targher, G.; Alberiche, M. y col. Homeostasis Model Assessment Closely Mirrors the Glucose Clamp Technique in the Assessment of Insulin Sensitivity. Diabetes Care 23: 57-63, 2000.
11. Litwak L.E.; Graffigna M.N.; Abdala M.M. y col. Prevalencia de factores de riesgo cardiovascular en sujetos presuntamente sanos. Estudio epidemiológico multicéntrico. (Resultados preliminares) RAEM 41: 206-213, 2004.
12. Pan XR, Li GW, Hu YH y col. Effects of diet and exercise in preventing NIDDM in people with impaired glucose tolerance. The Da Qing IGT and Diabetes Study. Diabetes Care 20: 537-44, 1997.
13. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. (Adult Treatment Panel III) (Special Communication) JAMA 285: 2486-2497, 2001.
14. Wallace, T.A.; Levy, J.C.; Matthews, D.R. Use and Abuse of HOMA Modeling. Diabetes Care 27: 1487-1495, 2004.
15. Cheng, C.; Campbell, K. L.; Kushner, H. y col. Correlation of Oral Glucose Tolerance Test-Derived Estimates of Insulin Sensitivity With Insulin Clamp Measurements in an African- American Cohort. Metabolism 53 (9): 1107-1112, 2004.
16. Fukushima, M.; Usami, M.; Ikeda, M. y col. Insulin Secretion and Insulin Sensitivity at Different Stages of Glucose Tolerance: A Cross-Sectional Study of Japanese Type 2 Diabetes. Metabolism 53 (7): 831-835, 2004
17. Ascaso, J. F.; Romero, P.; Real, J.T. y col. Cuantificación de insulinorresistencia con los valores de insulina basal e índice HOMA en una población no diabética. Medicina Clínica 117 (14): 530-533, 2001.
18. Bonora, E.; Kiechi, S.; Willeit, J. y col. Prevalence of Insulin Resistance in metabolic Disorders. The Bruneck Study. Diabetes 47: 1643-1648, 1998.